Clinical Trials Browser

Active not recruiting × Thyroid Neoplasms × Lapatinib × Clear all

NCT01947023 2026-05-14

Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery

Phase 1 Active not recruiting

Thyroid Neoplasms